Stock IVRO INVITRO INTERNATIONAL
Add to a list
To use this feature you must be a member
Log inSign up

Financials InVitro International

Equities

IVRO

US4618531036

Pharmaceuticals

Market Closed - OTC Markets
Other stock markets
 09:30:02 2024-05-09 am EDT 		5-day change 1st Jan Change
0.06 USD -3.69% Intraday chart for InVitro International -20.95% -14.29%
2017 InVitro International Announces Audited Consolidated Fourth Quarter and Full Year Ended September 30, 2016 CI
2016 InVitro International Announces Audited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended September 30, 2015 CI

Valuation

Fiscal Period: September 2018 2019 2020 2021 2022 2023
Capitalization 1 0.6935 1.211 2.504 3.869 1.479 1.303
Enterprise Value (EV) 1 -0.2178 0.1426 1.446 2.664 0.2469 0.1743
P/E ratio 12.9 x 18.3 x 55 x 42.5 x 69.3 x 885 x
Yield - - - - - -
Capitalization / Revenue 0.82 x 1.15 x 2.27 x 3.86 x 1.73 x 1.64 x
EV / Revenue -0.26 x 0.14 x 1.31 x 2.65 x 0.29 x 0.22 x
EV / EBITDA -3.79 x 2.04 x 42.2 x -106 x -2.17 x -7.94 x
EV / FCF -7.11 x 1.4 x -27.3 x 64.4 x -4.59 x -2.14 x
FCF Yield -14.1% 71.7% -3.67% 1.55% -21.8% -46.7%
Price to Book 0.64 x 0.99 x 1.89 x 2.71 x 1.02 x 0.9 x
Nbr of stocks (in thousands) 21,016 22,016 22,760 22,760 22,760 22,660
Reference price 2 0.0330 0.0550 0.1100 0.1700 0.0650 0.0575
Announcement Date 11/29/18 12/4/19 12/2/20 12/3/21 12/8/22 11/16/23
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: September 2018 2019 2020 2021 2022 2023
Net sales 1 0.8463 1.053 1.105 1.003 0.8535 0.7926
EBITDA 1 0.0575 0.07 0.0343 -0.025 -0.1138 -0.022
EBIT 1 0.0438 0.0614 0.0313 -0.0268 -0.1168 -0.0253
Operating Margin 5.18% 5.83% 2.83% -2.67% -13.68% -3.2%
Earnings before Tax (EBT) 1 0.0601 0.0823 0.0614 0.1055 0.0126 0.002353
Net income 1 0.0564 0.0707 0.0499 0.096 0.0213 0.001553
Net margin 6.67% 6.71% 4.52% 9.57% 2.49% 0.2%
EPS 2 0.002565 0.003000 0.001999 0.003999 0.000938 0.000065
Free Cash Flow 1 0.0306 0.1022 -0.053 0.0414 -0.0538 -0.0814
FCF margin 3.62% 9.71% -4.8% 4.12% -6.3% -10.27%
FCF Conversion (EBITDA) 53.25% 146.04% - - - -
FCF Conversion (Net income) 54.27% 144.61% - 43.08% - -
Dividend per Share - - - - - -
Announcement Date 11/29/18 12/4/19 12/2/20 12/3/21 12/8/22 11/16/23
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: September 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 0.91 1.07 1.06 1.21 1.23 1.13
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 0.03 0.1 -0.05 0.04 -0.05 -0.08
ROE (net income / shareholders' equity) 5.08% 5.98% 3.91% 6.96% 1.48% 0.11%
ROA (Net income/ Total Assets) 2.31% 2.97% 1.34% -1.06% -4.65% -1.04%
Assets 1 2.438 2.383 3.723 -9.091 -0.458 -0.1493
Book Value Per Share 2 0.0500 0.0600 0.0600 0.0600 0.0600 0.0600
Cash Flow per Share 2 0.0100 0.0200 0.0200 0.0200 0.0500 0.0200
Capex 1 0 - - 0 0.01 0
Capex / Sales 0.06% - - 0.31% 1.1% 0.11%
Announcement Date 11/29/18 12/4/19 12/2/20 12/3/21 12/8/22 11/16/23
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
INVITRO INTERNATIONAL Stock InVitro International
-14.29% 1.36M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+29.98% 682B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+31.83% 586B
JOHNSON & JOHNSON Stock Johnson & Johnson
-3.52% 364B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.59% 327B
ABBVIE INC. Stock AbbVie Inc.
+4.07% 285B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.23% 240B
NOVARTIS AG Stock Novartis AG
+9.34% 209B
ROCHE HOLDING AG Stock Roche Holding AG
-9.28% 203B
AMGEN INC. Stock Amgen Inc.
+7.09% 165B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. IVRO Stock
  4. Financials InVitro International
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW